Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(R)-6-Oxopiperidine-2-carboxylic acid REF: IN-DA005EBFCAS: 72002-30-3 | 98% | To inquire | Wed 08 Jan 25 | |
(R)-6-Oxopiperidine-2-carboxylic acid REF: 54-OR92199CAS: 72002-30-3 | 98% | 92.00 €~551.00 € | Wed 15 Jan 25 | |
D-6-Oxo-pipecolinic acid REF: 10-F040124CAS: 72002-30-3 | 97.0% | To inquire | Tue 21 Jan 25 | |
D-Pyrohomoglutamic Acid REF: TM-T71769CAS: 72002-30-3 | - - - | 121.00 €~796.00 € | Wed 26 Feb 25 | |
D-6-Oxopipecolinic acid REF: 3D-FO73278CAS: 72002-30-3 | Min. 95% | - - - | Discontinued product |
(R)-6-Oxopiperidine-2-carboxylic acid
CAS:72002-30-3
Formula:
C6H9NO3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
143.1406
Ref: IN-DA005EBF
1g | 111.00 € | ||
5g | 510.00 € | ||
25g | To inquire | ||
100mg | 45.00 € | ||
250mg | 60.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 54-OR92199
1g | 153.00 € | ||
5g | 551.00 € | ||
250mg | 92.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
D-6-Oxo-pipecolinic acid
CAS:72002-30-3
Purity:
97.0%
Color and Shape:
Solid
Molecular weight:
143.14199829101562
Ref: 10-F040124
1g | 110.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
D-Pyrohomoglutamic Acid
CAS:72002-30-3
D-Pyrohomoglutamic acid: used in LMP2 inhibitors synthesis and in substance P peptide analogs.
Formula:
C6H9NO3
Color and Shape:
Liquid
Molecular weight:
143.14
Ref: TM-T71769
50mg | 121.00 € | ||
100mg | 208.00 € | ||
250mg | 455.00 € | ||
500mg | 796.00 € |
Estimated delivery in United States, on Wednesday 26 Feb 2025
D-6-Oxopipecolinic acid
CAS:72002-30-3
D-6-Oxopipecolinic acid is a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to …
Formula:
C6H9NO3
Purity:
Min. 95%
Molecular weight:
143.14 g/mol
Ref: 3D-FO73278
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |